Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novamind Inc. NVMDF

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.


OTCQB:NVMDF - Post by User

Comment by yvreanon Apr 18, 2022 11:55am
93 Views
Post# 34610110

RE:RE:This is it!

RE:RE:This is it!I think that's the problemn as NUMI will trade down to .42 as that'll be the 0.84NUMI shares to value this at .36 exactly where it is right now.

There is a price to the value of this purchase and the higher NUMI shares are, the higher the price. I don't think they'll let that happen. I believe NM will stay at .36 and NUMI will go down to .42
<< Previous
Bullboard Posts
Next >>